ExploreWatchlistsPricing
  1. JP-listed companies
  2. TORII PHARMACEUTICAL CO., LTD.
  3. Financials
  4. Stockholders' equity

TORII PHARMACEUTICAL CO., LTD. (E00934)

Market cap
P/E ratio
Torii Pharmaceutical manufactures and sells prescription medicines for kidney disease, skin conditions, allergies, and other medical needs in Japan.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndStockholders' equity (Million JPY)YoY (%)
Dec 31, 2024121,533+1.16%
Dec 31, 2023120,134+0.76%
Dec 31, 2022119,224+1.89%
Dec 31, 2021117,015+1.67%
Dec 31, 2020115,091+1.74%
Dec 31, 2019113,125+29.89%
Dec 31, 201887,092-0.03%
Dec 31, 201787,119+4.26%
Dec 31, 201683,556+0.88%
Dec 31, 201582,826+3.24%
Dec 31, 201480,225+1.53%
Mar 31, 201479,018

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat